JILL JONES: Open Payments
NPI 1164630901 · LAGUNA NIGUEL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,321 in 99 payments from 26 companies in 2025. Trend: 2023 $1,960 · 2024 $2,077 · 2025 $2,321
Food & beverage: $2,321
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $319 |
| Insulet Corporation | 10 | $285 |
| Novo Nordisk Inc | 8 | $175 |
| Madrigal Pharmaceuticals | 8 | $159 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $138 |
| Mannkind Corporation | 7 | $131 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $103 |
| Amgen Inc. | 5 | $99 |
| Xeris Pharmaceuticals, Inc. | 4 | $90 |
| Lilly USA, LLC | 4 | $89 |
Products named: Omnipod, UBRELVY, JARDIANCE, REZDIFFRA, AFREZZA, Ozempic, Kerendia, TZIELD.
Industry payments across CA — which companies pay providers there.
